Controlled human infection models in COVID-19 and tuberculosis: current progress and future challenges

H Morrison, S Jackson, H McShane - Frontiers in Immunology, 2023 - frontiersin.org
Controlled Human Infection Models (CHIMs) involve deliberately exposing healthy human
volunteers to a known pathogen, to allow the detailed study of disease processes and …

Seroprevalence of anti-SARS-CoV-2 antibodies following the omicron BA. 1 wave

M Socan, K Prosenc, M Mrzel - International Journal of Environmental …, 2023 - mdpi.com
We conducted a seroprevalence study using convenient residual sera samples from the
Slovenian population collected after the end of the Omicron BA. 1 pandemic wave. Serum …

Learning from serosurveillance for SARS-CoV-2 to inform pandemic preparedness and response

SA Müller, A Agweyu, OA Akanbi, MA Alex-Wele… - The Lancet, 2023 - thelancet.com
The COVID-19 pandemic underlined the importance of serosurveillance as an evidence-
based tool to understand population immunity, track viral transmission, and guide public …

Risk factors for recognized and unrecognized SARS-CoV-2 infection: a seroepidemiologic analysis of the Prospective Urban Rural Epidemiology (PURE) study

DP Leong, M Loeb, PK Mony, S Rangarajan… - Microbiology …, 2024 - Am Soc Microbiol
There are limited data on individual risk factors for SARS-CoV-2 infection (including
unrecognized infection). In this seroepidemiologic substudy of an ongoing prospective …

SARS-CoV-2 seroepidemiology in Mongolia, 2020–2021: a longitudinal national study

B Chimeddorj, CR Bailie, U Mandakh… - The Lancet Regional …, 2023 - thelancet.com
Background The COVID-19 pandemic has global impacts but is relatively understudied in
developing countries. Mongolia, a lower-middle-income country, instituted strict control …

Trends in SARS-CoV-2 seroprevalence among pregnant women attending first antenatal care visits in Zambia: A repeated cross-sectional survey, 2021–2022

E Heilmann, T Tembo, S Fwoloshi… - PLOS Global Public …, 2024 - journals.plos.org
SARS-CoV-2 serosurveys help estimate the extent of transmission and guide the allocation
of COVID-19 vaccines. We measured SARS-CoV-2 seroprevalence among women …

Risk of SARS-CoV-2 infection and hospitalization in individuals with natural, vaccine-induced and hybrid immunity: a retrospective population-based cohort study from …

A Uusküla, H Pisarev, A Tisler, T Meister, K Suija… - Scientific Reports, 2023 - nature.com
A large proportion of the world's population has some form of immunity against SARS-CoV-
2, through either infection ('natural'), vaccination or both ('hybrid'). This retrospective cohort …

[HTML][HTML] Characterizing the evolving SARS-CoV-2 seroprevalence in urban and rural Malawi between February 2021 and April 2022: A population-based cohort study

L Banda, A Ho, S Kasenda, JM Read, C Jewell… - International Journal of …, 2023 - Elsevier
Objectives This study aimed to investigate the changing SARS-CoV-2 seroprevalence and
associated health and sociodemographic factors in Malawi between February 2021 and …

Factors Affecting SARS-CoV-2 IgG Production after Vaccination and/or Disease: A Large-Scale Seroprevalence Study

T Karl, A Schuster, LM Stangassinger, T Stiboller… - Vaccines, 2023 - mdpi.com
This study aimed at identifying factors influencing SARS-CoV-2-specific IgG antibody levels
after vaccination and/or infection. Between January 2022 and March 2023, 2000 adults (≥ …

SARS-CoV-2 seroprevalence and associated factors, based on HIV serostatus, in young people in Sofala province, Mozambique

R Benoni, V Casigliani, A Zin, D Giannini… - BMC Infectious …, 2023 - Springer
Abstract Introduction In Sofala province (Mozambique), young people living with HIV
(YPLHIV) are estimated at 7% among people aged 15–24 years. Even though the COVID-19 …